Peter Rickli
Corporate Officer/Principal at The Genetics Co., Inc.
Network origin in Peter Rickli first degree
Entity | Entity type | Industry | |
---|---|---|---|
The Genetics Co., Inc.
The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates.
3
| Private Company | Medical/Nursing Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Peter Rickli via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Investment Managers | Private Equity Investor Chief Executive Officer | |
University of Basel | College/University | Undergraduate Degree Doctorate Degree | |
Rising Tide Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
Swiss Federal Institute of Technology | College/University | Chief Administrative Officer | |
8stogg AG | Director/Board Member | ||
Wemedoo AG | Chairman | ||
NOVIMMUNE SA | Medical/Nursing Services | Director/Board Member | |
AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member | |
SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member | |
Nextech Venture Principals Ltd.
Nextech Venture Principals Ltd. Financial ConglomeratesFinance Nextech Venture Principals Ltd. provides investment services. The private company is based in Jersey. | Financial Conglomerates | Director/Board Member | |
BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member | |
Mahissa | Chief Executive Officer | ||
IMPLENIA AG | Engineering & Construction | Director/Board Member | |
Varuma AG | Corporate Officer/Principal | ||
Elanco Tiergesundheit AG
Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Swiss Scientific Computing Center
Swiss Scientific Computing Center Miscellaneous Commercial ServicesCommercial Services The Swiss Scientific Computing Center develops and provides supercomputing capabilities to solve important problems in science and society. The private company is based in Manno, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Dottikon Es Management AG | Director/Board Member | ||
Dottikon Exclusive Synthesis AG
Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Nextech III GP AG | Director/Board Member | ||
TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Nextech Holding AG | Chairman | ||
DOTTIKON ES HOLDING AG | Chemicals: Specialty | Director/Board Member | |
Kyoto University | College/University | Graduate Degree | |
SynphaBase AG
SynphaBase AG Miscellaneous Commercial ServicesCommercial Services SynphaBase AG provides contract research and development services to the pharmaceutical and chemical industry. Its products and services include route finding and process development, production of multi-kg up to metric tons, lab scale synthesis and carbohydrates and glycans. The firm’s catalogue includes monosaccharides as building blocks for glycan synthesis with various protecting group patterns and linker systems, disaccharides, oligosaccharides, glycosyl amino acids; core structures and building blocks for carbohydrate-based vaccine. The company was founded by in Arthur Bodenmüller in December 2000 and is headquartered in Pratteln, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Covagen AG
Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Chairman | |
Novartis Venture Funds
Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz. | Investment Managers | President | |
Stanford University | College/University | Undergraduate Degree | |
Basel Chamber of Commerce
Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistics
International
Switzerland | 29 |
United States | 6 |
Germany | 2 |
Spain | 2 |
Japan | 2 |
Sectoral
Health Technology | 14 |
Commercial Services | 6 |
Consumer Services | 5 |
Finance | 4 |
Miscellaneous | 2 |
Operational
Director/Board Member | 24 |
Corporate Officer/Principal | 7 |
Chairman | 4 |
Chief Executive Officer | 4 |
Undergraduate Degree | 2 |
Most connected contacts
Insiders | |
---|---|
Alfred Scheidegger | 20 |
Hans-Beat Gürtler | 13 |
Rudolf Gygax | 9 |
- Stock Market
- Insiders
- Peter Rickli
- Company connections